New horizons for cell therapy: emerging platforms

CELL AND GENE THERAPY INSIGHTS

October 2021

New horizons for cell therapy: emerging platforms

Download PDF

Editorial

A model for where we live

A model for where we live

25 November 2021

Mass cytometry for comprehensive immune profiling in CAR T cell

Mass cytometry for comprehensive immune profiling in CAR T cell

Sneha Ramakrishna

18 November 2021

Engineering new killers: bringing NK cells to the battle against cancer

Engineering new killers: bringing NK cells to the battle against cancer

Tamara J Laskowski, Sunil Acharya, Mayra Shanley

17 November 2021

Full spectrum flow cytometry: a powerful cytometric analysis to benefit cell therapy

Full spectrum flow cytometry: a powerful cytometric analysis to benefit cell therapy

Ana Leda Figueiredo Longhini

10 November 2021

Expert Insight

Artificial intelligence: accelerating translational cell therapy development through computational methods for neoepitope discovery

Artificial intelligence: accelerating translational cell therapy development through computational methods for neoepitope discovery

M Chiriva-Internati, L Piccotti, L Zammataro et al.

25 November 2021

Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?

Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?

Matthias Bozza, Richard Harbottle

23 November 2021

Expert Roundtable Video

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Isabelle Riviére, Metin Kurtoglu, Tariq Haq

22 November 2021

Expert Roundtable

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

22 November 2021

Podcast

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

25 November 2021

Interview

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

Daniel Corey, John Rossi, Remus Vezan

25 November 2021

Critical success factors for tomorrow’s cellular immunotherapies

Critical success factors for tomorrow’s cellular immunotherapies

17 November 2021

A question of control? Next steps for novel TIL therapeutics

A question of control? Next steps for novel TIL therapeutics

Jan ter Meulen MD PhD

17 November 2021

Enhancing the depth and durability of patient responses to CAR T cell therapy

Enhancing the depth and durability of patient responses to CAR T cell therapy

Jennifer Brogdon

17 November 2021